EGFR and neoplasm: In addition, Ohno et al. [6] used genetic engineering technology to manufacture GE11 targeting peptide modified exosomes (GE11-Exos) and use GE11-Exos to target tumor suppressor miRNAs to breast cancer tissues with high expression of EGFR on the cell membrane surface.